The Immunomodulator Fty720 and Its Phosphorylated Derivative Activate the Smad Signalling Cascade and Upregulate Connective Tissue Growth Factor and Collagen Type Iv Expression in Renal Mesangial Cells.
From: Pharmazentrum frankfurt Izafes, Klinikum der Johann Wolfgang Goethe-Universität, Theodor-Stern-Kai 7, D-60590 Frankfurt am Main, Germany.
British journal of pharmacology
- Publish Date: Jan 2006
- ISSN: 0007-1188
- Volume: 147
- Issue: 2
- Pages: 164-74
- Medium: Print
- Language: English
- Citation (JAMA): Xin Cuiyan, Ren Shuyu, Eberhardt Wolfgang, et al. The Immunomodulator Fty720 and Its Phosphorylated Derivative Activate the Smad Signalling Cascade and Upregulate Connective Tissue Growth Factor and Collagen Type Iv Expression in Renal Mesangial Cells.. Br. J. Pharmacol. Jan 2006;147:164-74
Abstract
1. — The immunomodulating agent FTY720 is a substrate for the sphingosine kinase and the phosphorylated form is able to bind to sphingosine 1-phosphate (S1P) receptors. In this study, we show that exposure of renal mesangial cells to phospho-FTY720 leads to a rapid and transient activation of several protein kinase cascades, including the mitogen- and stress-activated protein kinases. The nonphosphorylated FTY720 also increased MAPK phosphorylation, but with a reduced potency and a more delayed time course. In addition, phospho-FTY720 and FTY720 are able to increase phosphorylation of Smad proteins which are classical members of the transforming growth factor-beta (TGF-beta) signalling device, thus suggesting a crosstalk between FTY720 and TGF-beta signalling. 2. — Pretreatment with the S1P(3) receptor antagonist suramin inhibits FTY720 and phospho-FTY720-induced Smad phosphorylation, whereas pertussis toxin pretreatment, which blocks G(i/0) proteins, has no effect on Smad phosphorylation. 3. — Since TGF-beta is a potent profibrotic cytokine in mesangial cells and upregulates the connective tissue growth factor (CTGF) and collagen as important hallmarks in the fibrotic sequelae, we investigated whether FTY720 and phospho-FTY720 are able to mimic these effects of TGF-beta. Indeed, FTY720 and phospho-FTY720 markedly upregulate CTGF and collagen type IV protein expressions. In addition, the tissue inhibitor of metalloproteinase-1 is transcriptionally activated by FTY720, whereas cytokine-induced matrix metalloproteinase-9 is down-regulated by FTY720. 4. — Depletion of the TGF-beta receptor type II by the siRNA transfection technique blocks not only Smad phosphorylation but also CTGF upregulation. Similarly, Smad-4 depletion by siRNA transfection also abrogates CTGF upregulation induced by FTY720 and phospho-FTY720. 5. — In summary, our data show that FTY720 and phospho-FTY720 not only activate the Smad signalling cascade in mesangial cells, but also upregulate the expression of CTGF and collagen. These findings suggest that FTY720 may have additional effects besides the established immunomodulatory action and, importantly, a profibrotic activity has to be considered in future experimental approaches.
Mesh Headings (Keywords): Animals, Cells, Cultured, Collagen Type IV, Fibrosis, Glomerular Mesangium, Immediate-Early Proteins, Immunosuppressive Agents, Intercellular Signaling Peptides and Proteins, MAP Kinase Signaling System, Male, Phosphorylation, Propylene Glycols, Rats, Rats, Sprague-Dawley, Signal Transduction, Smad Proteins, Smad1 Protein, Smad2 Protein, Smad3 Protein, Sphingosine, Transforming Growth Factor beta, Up-Regulation
Check for Full Text / PubMed Unique Identifier (PMID): 16299553
This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.
Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.
The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.